JP2022130527A5 - - Google Patents

Download PDF

Info

Publication number
JP2022130527A5
JP2022130527A5 JP2022100650A JP2022100650A JP2022130527A5 JP 2022130527 A5 JP2022130527 A5 JP 2022130527A5 JP 2022100650 A JP2022100650 A JP 2022100650A JP 2022100650 A JP2022100650 A JP 2022100650A JP 2022130527 A5 JP2022130527 A5 JP 2022130527A5
Authority
JP
Japan
Prior art keywords
peptide
inhibitor
seq
thrombin
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022100650A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022130527A (ja
Filing date
Publication date
Priority claimed from PCT/AU2017/051405 external-priority patent/WO2018107247A1/en
Application filed filed Critical
Publication of JP2022130527A publication Critical patent/JP2022130527A/ja
Publication of JP2022130527A5 publication Critical patent/JP2022130527A5/ja
Pending legal-status Critical Current

Links

JP2022100650A 2016-12-16 2022-06-22 脳卒中および関係する凝固性障害の処置のためのトロンビン阻害剤 Pending JP2022130527A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2016905231 2016-12-16
AU2016905231A AU2016905231A0 (en) 2016-12-16 Thrombin inhibitors for treatment of stroke and related coagulative disorders
PCT/AU2017/051405 WO2018107247A1 (en) 2016-12-16 2017-12-15 Thrombin inhibitors for treatment of stroke and related coagulative disorders
JP2019531876A JP2020501561A (ja) 2016-12-16 2017-12-15 脳卒中および関係する凝固性障害の処置のためのトロンビン阻害剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019531876A Division JP2020501561A (ja) 2016-12-16 2017-12-15 脳卒中および関係する凝固性障害の処置のためのトロンビン阻害剤

Publications (2)

Publication Number Publication Date
JP2022130527A JP2022130527A (ja) 2022-09-06
JP2022130527A5 true JP2022130527A5 (cg-RX-API-DMAC7.html) 2022-10-11

Family

ID=62557849

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019531876A Pending JP2020501561A (ja) 2016-12-16 2017-12-15 脳卒中および関係する凝固性障害の処置のためのトロンビン阻害剤
JP2022100650A Pending JP2022130527A (ja) 2016-12-16 2022-06-22 脳卒中および関係する凝固性障害の処置のためのトロンビン阻害剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019531876A Pending JP2020501561A (ja) 2016-12-16 2017-12-15 脳卒中および関係する凝固性障害の処置のためのトロンビン阻害剤

Country Status (8)

Country Link
US (1) US11091535B2 (cg-RX-API-DMAC7.html)
EP (1) EP3555116A4 (cg-RX-API-DMAC7.html)
JP (2) JP2020501561A (cg-RX-API-DMAC7.html)
CN (1) CN110139871A (cg-RX-API-DMAC7.html)
AU (1) AU2017376839B2 (cg-RX-API-DMAC7.html)
CA (1) CA3047159A1 (cg-RX-API-DMAC7.html)
NZ (1) NZ754781A (cg-RX-API-DMAC7.html)
WO (1) WO2018107247A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110590911B (zh) * 2019-09-30 2021-10-22 华南理工大学 一种含酪氨酸硫酸化修饰的多肽合成方法及其应用
US20230416341A1 (en) * 2020-06-19 2023-12-28 The University Of Sydney Improved thrombin inhibitors for treatment of thromboembolic conditions
CN114887123B (zh) * 2022-04-18 2023-07-04 南通大学 水蛭素接枝纳米纤维血管支架材料、制备方法与应用
CN119462906B (zh) * 2024-11-11 2026-06-05 北京元启合生科技有限公司 一种酪氨酸硫酸化的重组水蛭素、制备方法及其用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4323754C1 (de) * 1993-07-15 1994-12-01 Gruenenthal Gmbh Bifunktionelle Urokinasevarianten mit verbesserten fibrinolytischen Eigenschaften und thrombinhemmender Wirkung
US6759384B1 (en) * 1994-04-26 2004-07-06 Aventis Pharmaceuticals Inc. Factor Xa inhibitors
AU5903000A (en) * 1999-06-29 2001-01-31 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Novel anti-thrombin peptide
EP1240194A2 (en) 1999-11-24 2002-09-18 Sugen, Inc. Novel human protein kinases and protein kinase-like enzymes
EP1425296B1 (de) * 2001-09-10 2011-04-13 Novel Science International GmbH Organische verbindungen mit biologischer wirkung als thrombinhemmer und ihre verwendung
JP3648548B2 (ja) * 2001-10-15 2005-05-18 国立大学法人三重大学 血液凝固阻害活性を有するハマダラカ由来のAs−1蛋白質
DE10301255A1 (de) * 2003-01-15 2004-07-29 Cpi Creative Pharma International Gmbh Organische Verbindungen mit biologischer Wirkung als Thrombinhemmer und ihre Verwendung
EP1856147A4 (en) 2005-02-15 2008-07-02 Apollo Life Sciences Ltd MOLECULE AND CHIMESE MOLECULES THEREOF
US20070298034A9 (en) * 2005-12-09 2007-12-27 Angela Widom Sulfotyrosine specific antibodies and uses therefor
CN100595208C (zh) * 2006-07-31 2010-03-24 浙江中医药大学 硫酸化丝素蛋白的制备方法及其在抗凝血药物上的应用
GB0711779D0 (en) * 2007-06-18 2007-07-25 Univ Singapore Thrombin inhibitor
GB0907698D0 (en) * 2009-05-05 2009-06-10 Univ Singapore Method of modifying serine protease inhibitors
WO2012024543A1 (en) 2010-08-18 2012-02-23 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease
US9777123B2 (en) * 2013-05-30 2017-10-03 Virginia Commonwealth University Sulfated beta-O4 low molecular weight lignins
DK3004134T3 (da) 2013-06-04 2019-05-13 Univ Sydney Peptid-ligering
US11279771B2 (en) 2014-09-17 2022-03-22 Novo Nordisk A/S Antibodies capable of binding two epitopes on tissue factor pathway inhibitor (1-161)
US20230416341A1 (en) * 2020-06-19 2023-12-28 The University Of Sydney Improved thrombin inhibitors for treatment of thromboembolic conditions

Similar Documents

Publication Publication Date Title
JP2023518596A5 (cg-RX-API-DMAC7.html)
IL261432B1 (en) Induced binding proteins and methods of use
JP2013502458A5 (cg-RX-API-DMAC7.html)
JP2015512876A5 (cg-RX-API-DMAC7.html)
RU2003104524A (ru) Masp-2, комплемент-связывающий фермент и его применение
JP2002500886A5 (cg-RX-API-DMAC7.html)
DK1349944T3 (da) Latensassocieret peptid af TGF-beta til at bibringe farmaceutisk aktive proteiner latens
NO20025153D0 (no) FremgangsmÕter og sammensetninger for Õ svekke formering av HIV-1
CN116096736A (zh) 新型冠状病毒rbd融合蛋白
EP0827539A2 (en) Kunitz type protease inhibitors
JP2023545707A5 (cg-RX-API-DMAC7.html)
JP2012525836A5 (cg-RX-API-DMAC7.html)
JP2017521074A5 (cg-RX-API-DMAC7.html)
JP2023542453A5 (cg-RX-API-DMAC7.html)
CN100577686C (zh) 寡聚肽及其治疗hiv感染的用途
JP2006516113A5 (cg-RX-API-DMAC7.html)
WO2005123771B1 (en) Oligomeric peptides and their use for the treatment of hiv infections
CZ334095A3 (en) Compounds containing chains of amino acids, their use and pharmaceutical compositions containing thereof
WO2009038729A3 (en) Compositions and methods utilizing fibrin beta chain fragments of the bbeta chain of fibrinogen
Weithauser et al. The role of protease-activated receptors for the development of myocarditis: possible therapeutic implications
WO2002002148A3 (en) Dual recombinant gene therapy compositions and methods of use
US20020173620A1 (en) Bifunctional fusion proteins formed from hirudin and TAP
US8968728B2 (en) Chimeric fusion proteins
Sheffield et al. A long-lasting, plasmin-activatable thrombin inhibitor aids clot lysis in vitro and does not promote bleeding in vivo
JP5053991B2 (ja) ペプチド安定化化合物とスクリーニング方法